Thrombotic Microangiopathies/Thrombocytopenias and COVID-19-related Thrombotic/Vascular Disorders: Clinical and Epidemiological Comparing the Impact of Rituximab Dosing on Longitudinal ADAMTS13 Parameters in TTP

被引：0
|
作者：
Subhan, Maryam [1 ]
Prasannan, Nithya [2 ]
Dragunaite, Bertina [1 ]
Vanhoorelbeke, Karen [3 ]
Scully, Marie [4 ]
Thomas, Mari [2 ]
机构：
[1] UCL, London, England
[2] Univ Coll London Hosp, London, England
[3] Katholieke Univ Leuven, Lab Thrombosis Res, Kortrijk, Belgium
[4] UCL, London, England
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-190542
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 6 条
  • [1] Thrombotic Microangiopathies/Thrombocytopenias and COVID-19-related Thrombotic/Vascular Disorders: Clinical and Epidemiological Thrombotic Thrombocytopenic Purpura (TTP) Survivors Exhibit Impaired Stress Perfusion on Cardiac MRI
    Sukumar, Senthil
    Danish, Leah
    Li, Ang
    Han, Yuchi
    Cataland, Spero
    BLOOD, 2023, 142
  • [2] Thrombotic Microangiopathies/Thrombocytopenias and COVID-19-related Thrombotic/Vascular Disorders: Clinical and Epidemiological Persistent ADAMTS13 Inhibitor May Lead to Delayed ADAMTS13 Recovery in Japanese Patients with Caplacizumab-Treated Immune-Mediated Thrombotic Thrombocytopenic Purpura
    Saito, Kenki
    Sakai, Kazuya
    Kubo, Masayuki
    Azumi, Hidekazu
    Hamamura, Atsushi
    Ochi, Shinichi
    Kobayashi, Shinya
    Yagi, Hideo
    Matsumoto, Masanori
    BLOOD, 2023, 142
  • [3] Thrombotic Microangiopathies/Thrombocytopenias and COVID-19-related Thrombotic/Vascular Disorders: Clinical and Epidemiological Recombinant ADAMTS13 for the Treatment of Acute TTP Events in Patients with Congenital Thrombotic Thrombocytopenic Purpura: Results from the Phase 3 Randomized, Controlled, Crossover Study and the Phase 3b Continuation Study
    Scully, Marie
    Ortel, Thomas L.
    Yu, Ziqiang
    Zhang, Pinghai
    Patel, Munjal
    Patwari, Parth
    Mellgard, Bjorn
    Wang, Linda T.
    BLOOD, 2023, 142
  • [4] Thrombotic Microangiopathies/Thrombocytopenias and COVID-19-related Thrombotic/Vascular Disorders: Clinical and Epidemiological Value of Prophylactic Plasma Treatment and Incidence of Acute Episodes in Patients Enrolled in the International Hereditary Thrombotic Thrombocytopenic Purpura Registry
    Schraner, Marissa
    Tarasco, Erika
    Stalder, Odile
    Friedman, Kenneth D.
    George, James N.
    Hrachovinova, Ingrid
    Knoebl, Paul N.
    Matsumoto, Masanori
    Schneppenheim, Reinhard
    Von Krogh, Anne-Sophie
    Cermakova, Zuzana
    Gorska-Kosicka, Magdalena
    Sakai, Kazuya
    Sinkovits, Gyoergy
    El Chazli, Yasmine
    Largiader, Carlo R.
    Pikovsky, Oleg
    Windyga, Jerzy
    Laemmle, Bernhard
    Hovinga, Johanna A. Kremer
    BLOOD, 2023, 142
  • [5] Thrombotic Microangiopathies/Thrombocytopenias and COVID-19-related Thrombotic/Vascular Disorders: Clinical and Epidemiological Estimating the Population-Based Prevalence of Congenital Thrombotic Thrombocytopenic Purpura Using Large-Scale Sequencing Data
    Seidizadeh, Omid
    Cairo, Andrea
    Mancini, Ilaria
    Agosti, Pasquale
    Rosendaal, Frits
    Peyvandi, Flora
    BLOOD, 2023, 142
  • [6] Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the Harvard TMA Research Collaborative
    Bendapudi, Pavan K.
    Li, Ang
    Hamdan, Ayad
    Uhl, Lynne
    Kaufman, Richard
    Stowell, Christopher
    Dzik, Walter
    Makar, Robert S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 (05) : 836 - 844
1